UnitedHealth Group Incorporated $UNH Stock Position Lowered by GTS Securities LLC

GTS Securities LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 72.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,405 shares of the healthcare conglomerate’s stock after selling 3,727 shares during the quarter. GTS Securities LLC’s holdings in UnitedHealth Group were worth $584,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of UNH. Cookson Peirce & Co. Inc. purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $297,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of UnitedHealth Group by 4.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 272,738 shares of the healthcare conglomerate’s stock valued at $113,358,000 after purchasing an additional 10,790 shares during the period. Private Management Group Inc. acquired a new stake in shares of UnitedHealth Group during the second quarter worth approximately $214,000. Rational Advisors Inc. increased its stake in UnitedHealth Group by 630.5% in the 2nd quarter. Rational Advisors Inc. now owns 2,155 shares of the healthcare conglomerate’s stock valued at $896,000 after buying an additional 1,860 shares during the period. Finally, Meiji Yasuda Life Insurance Co grew its holdings in shares of UnitedHealth Group by 68.8% during the 2nd quarter. Meiji Yasuda Life Insurance Co now owns 9,529 shares of the healthcare conglomerate’s stock valued at $3,961,000 after acquiring an additional 3,884 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE UNH opened at $393.99 on Monday. The company has a market cap of $353.64 billion, a P/E ratio of 25.35, a P/E/G ratio of 1.36 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a fifty day simple moving average of $413.28 and a 200 day simple moving average of $360.71.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is 59.72%.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on UNH shares. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Erste Group Bank downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $287.00 to $453.00 in a research note on Thursday, July 16th. Finally, JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $456.56.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.